Company profile
CureAge Therapeutics
Curing peripheral nerve disorders with genetic medicine
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2024
CureAge Therapeutics company summary
CureAge Therapeutics is a company in the Biotechnology Research industry, founded in 2024. On LinkedIn the company has around 5 employees.
What technology does CureAge Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About CureAge Therapeutics
We develop genetic medicines to improve the future of people living with peripheral nerve diseases, starting with Neurofibromatosis type 1 (NF1). Founded by the Children’s Tumor Foundation and Deep Science Ventures, CureAge brings together patients, scientists, and entrepreneurs to build the first curative therapy for NF1 and other Schwann cell-related disorders.
Compare companies similar to CureAge Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
CureAge Therapeutics cureagetx.com | Biotechnology Research | 5 | 2024 | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about CureAge Therapeutics
What does CureAge Therapeutics do?
We develop genetic medicines to improve the future of people living with peripheral nerve diseases, starting with Neurofibromatosis type 1 (NF1). Founded by the Children’s Tumor Foundation and Deep Science Ventures, CureAge brings together patients, scientists, and entrepreneurs to build the first curative therapy for NF1 and other Schwann cell-related disorders.
How many employees does CureAge Therapeutics have?
CureAge Therapeutics has around 5 employees on LinkedIn.
When was CureAge Therapeutics founded?
CureAge Therapeutics was founded in 2024.
Build a lead list from companies like CureAge Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.